Evaluation of Recurrence in 36 Subacute Thyroiditis Patients Managed with Prednisolone.

Abstract

The recurrence rate of SAT with treated PSL is about 20%. There was no difference in the laboratory data before starting the therapy between recurrent and non-recurrent groups. Therefore, a modified protocol of PSL administration may be needed to decrease the early recurrent rate of SAT.